Document 0776 DOCN M9440776 TI The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology. DT 9404 AU Stoiber H; Thielens NM; Ebenbichler C; Arlaud GJ; Dierich MP; Institut fur Hygiene, Leopold-Franzens-University, Innsbruck,; Austria. SO Eur J Immunol. 1994 Feb;24(2):294-300. Unique Identifier : AIDSLINE MED/94130941 AB gp41, the transmembrane glycoprotein of HIV-1, has been shown to be non-covalently associated with gp120. We have shown that it also binds human C1q. To analyze the interaction site(s) of gp41 with these two molecules, we established an enzyme-linked immunosorbent assay (ELISA) system using recombinant soluble gp41 [amino acids (aa) 539-684] and peptides thereof. In the cell-external part of gp41 three sites (aa 526-538, aa 590-613 and aa 625-655) were found to bind both gp120 and C1q. That gp120 and C1q use the same sites was evidenced by the fact that these proteins competed with each other for the same sites in recombinant soluble gp41 and gp41 peptides. It could be demonstrated by ELISA, that rabbit antibodies against human C1q recognized gp120, and rabbit antibodies against gp120 cross-reacted with C1q. Rabbit anti-gp120, HIV-1-positive human sera and anti-gp120 obtained from such sera agglutinated sensitized sheep erythrocytes with human C1q (EAC1q). These data suggest that in addition to functional homology between C1q and gp120 structural homology between these two molecules exists. This molecular mimicry might become the basis for immunologically relevant autoimmune phenomena. DE Antigenic Determinants Binding Sites Complement 1q/*IMMUNOLOGY/METABOLISM Human HIV Envelope Protein gp120/*IMMUNOLOGY/METABOLISM HIV Envelope Protein gp41/*IMMUNOLOGY/METABOLISM HIV Seropositivity/IMMUNOLOGY In Vitro Peptides/CHEMISTRY/IMMUNOLOGY Protein Binding Recombinant Proteins Support, Non-U.S. Gov't JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).